Clinical Air Episode #13 Transcelerate & Industry Engagement
PharmaTalkRadio16 Jan 2015

Clinical Air Episode #13 Transcelerate & Industry Engagement

In September 2012, TransCelerate Biopharma launched with the aim of simplifying and accelerating the delivery of innovative medicines to patients. What progress has really been made and what are the realistic goals for 2015? In our 2015 kick off radio show, Clinical Air Episode #13, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer talks with Dalvir Gill, PhD, CEO of Transcelerate and Andy Lee, MD, SVP, Head of Global Clinical Trial Operations at Merck. In this frank discussion, we learn: What’s working well and changes for 2015?Is Tanscelerate performing better or differently from other collaborations?How have engagements with outside organizations advanced? Where do gaps remain?How are new areas selected and scope defined?Thoughts on implementing new ideasNew role for CROsWhat deliverables does Tanscelerate anticipate for 2015?

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
hacka-livet
bildningspodden
ufo-sverige
rss-vetenskapsradion
rss-ufobortom-rimligt-tvivel
sexet
medicinvetarna
halsorevolutionen
rss-vetenskapsradion-2
det-morka-psyket
svd-nyhetsartiklar
paranormalt-med-caroline-giertz
ufo-sverige-2
rss-kriminologerna
vetenskapsradion
rss-spraket
rss-tidslinjen-podcast